Northern Trust’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9K | Hold |
100,828
| – | – | ﹤0.01% | 4268 |
|
|
2025
Q1 | $35K | Buy |
100,828
+6
| +0% | +$2 | ﹤0.01% | 4283 |
|
|
2024
Q4 | $59.6K | Buy |
100,822
+12,041
| +14% | +$7.12K | ﹤0.01% | 4242 |
|
|
2024
Q3 | $156K | Sell |
88,781
-238,763
| -73% | -$420K | ﹤0.01% | 3952 |
|
|
2024
Q2 | $449K | Sell |
327,544
-26,396
| -7% | -$36.2K | ﹤0.01% | 3546 |
|
|
2024
Q1 | $1.22M | Sell |
353,940
-1,954
| -0.5% | -$6.72K | ﹤0.01% | 3227 |
|
|
2023
Q4 | $875K | Sell |
355,894
-1,466
| -0.4% | -$3.61K | ﹤0.01% | 3357 |
|
|
2023
Q3 | $608K | Sell |
357,360
-7,418
| -2% | -$12.6K | ﹤0.01% | 3462 |
|
|
2023
Q2 | $1.09M | Buy |
364,778
+274,377
| +304% | +$823K | ﹤0.01% | 3324 |
|
|
2023
Q1 | $242K | Buy |
90,401
+5,018
| +6% | +$13.4K | ﹤0.01% | 3771 |
|
|
2022
Q4 | $704K | Buy |
85,383
+13,528
| +19% | +$112K | ﹤0.01% | 3384 |
|
|
2022
Q3 | $553K | Buy |
71,855
+18,072
| +34% | +$139K | ﹤0.01% | 3475 |
|
|
2022
Q2 | $153K | Sell |
53,783
-120,288
| -69% | -$342K | ﹤0.01% | 4018 |
|
|
2022
Q1 | $871K | Sell |
174,071
-5,977
| -3% | -$29.9K | ﹤0.01% | 3489 |
|
|
2021
Q4 | $3.54M | Buy |
180,048
+3,848
| +2% | +$75.6K | ﹤0.01% | 2911 |
|
|
2021
Q3 | $5.19M | Buy |
176,200
+29,048
| +20% | +$855K | ﹤0.01% | 2707 |
|
|
2021
Q2 | $6.24M | Buy |
147,152
+24,412
| +20% | +$1.03M | ﹤0.01% | 2715 |
|
|
2021
Q1 | $6.24M | Buy |
+122,740
| New | +$6.24M | ﹤0.01% | 2611 |
|